Ignite Creation Date:
2025-12-24 @ 6:32 PM
Ignite Modification Date:
2026-02-03 @ 4:35 PM
Study NCT ID:
NCT01399957
Status:
COMPLETED
Last Update Posted:
2015-11-10
First Post:
2011-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients
Sponsor:
Mount Sinai Rehabilitation Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AL0003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None